0001493152-12-001829.txt : 20121128 0001493152-12-001829.hdr.sgml : 20121128 20121128172339 ACCESSION NUMBER: 0001493152-12-001829 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20121128 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20121128 DATE AS OF CHANGE: 20121128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Q Holdings, Inc. CENTRAL INDEX KEY: 0001366541 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203708500 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52062 FILM NUMBER: 121229807 BUSINESS ADDRESS: STREET 1: 615 ARAPEEN DRIVE STREET 2: SUITE 102 CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: (801) 582-5400 MAIL ADDRESS: STREET 1: 615 ARAPEEN DRIVE STREET 2: SUITE 102 CITY: SALT LAKE CITY STATE: UT ZIP: 84108 FORMER COMPANY: FORMER CONFORMED NAME: Grace 2, Inc. DATE OF NAME CHANGE: 20060619 8-K 1 form8k.htm FORM 8-K

 

 

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 28, 2012

 

Q HOLDINGS, INC.

 (Exact name of registrant as specified in its charter)

 

Delaware   000-52062   20-3708500
(State or other Jurisdiction of   (Commission File Number)   (IRS Employer Identification No.)
Incorporation)        

 

615 Arapeen Drive, Suite 102    
Salt Lake City, UT   84108
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (801) 582-5400

 

 
(Former name or former address if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

  

 
 

 

 

Item 8.01 Other Events.

 

Q Holdings, Inc., dba Q Therapeutics, Inc., (Q Holdings) announced the issuance of United States Patent No. 8,168,174, covering a method of replacing damaged neural cells in humans by transplanting an isolated population of human neuroepithelial precursor cells; and the issuance of Canadian Patent No. CA 2,473,749, covering populations of mammalian astrocyte restricted precursor cells and their use for treating damaged neural cells, enhancing myelination and reducing scar formation. A copy of the press release announcing the issuance of the patents is attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Number   Exhibit
99.1   Press Release dated November 28, 2012, entitled “Q Therapeutics Announces U.S. and Canadian Patent Awards.” 

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

 

Date: November 28, 2012 Q HOLDINGS, INC.
     
  By: /s/ Steven J. Borst
    Steven J. Borst,
    Vice President and Chief Financial Officer

 

 
 

 

 

EXHIBIT INDEX

Q HOLDINGS, INC.

 

Number   Exhibit
99.1   Press Release dated November 28, 2012, entitled “Q Therapeutics Announces U.S. and Canadian Patent Awards.” 

 

 
 

 

 EX-99.1 CHARTER 2 ex99-1.htm Exhibit 99.1

 

Exhibit 99.1

 

 

Q THERAPEUTICS ANNOUNCES U.S. AND CANADIAN PATENT AWARDS

 

Salt Lake City, UT – (Marketwire) – November 28, 2012 – Q Holdings, Inc., dba Q Therapeutics, Inc., an emerging biotechnology company utilizing its proprietary innovative technology to develop breakthrough cell therapy products for the treatment of debilitating diseases of the central nervous system, today announced the issuance of United States Patent No. 8,168,174, covering a method of replacing damaged neural cells in humans by transplanting an isolated population of human neuroepithelial precursor cells; and the issuance of Canadian Patent No. CA 2,473,749, covering populations of mammalian astrocyte restricted precursor cells and their use for treating damaged neural cells, enhancing myelination and reducing scar formation.

 

These newly issued patents protect core technologies on neural lineage stem cells as well as progenitor cells in the glial astrocytic lineage of the central nervous system that complement the Company’s Q-Cells® product. Q-Cells is a cell-based therapeutic currently in development by Q Therapeutics that is intended to restore or preserve activity of neurons by providing support functions that naturally occur in healthy central nervous system tissue. Originally developed by Q Therapeutics’ co-founder Mahendra Rao, MD, PhD while he was at the University of Utah and National Institutes of Health, this technology has been exclusively licensed to Q Therapeutics by the University and the NIH.

 

“We are very pleased with these most recent patent issuances, which expand and enhance our intellectual property estate on other neural cell types, complementing our promising Q-Cells research and development platform,” stated Deborah Eppstein, PhD, President and CEO of Q Therapeutics. “These new patents are now included among 16 patents that have been issued to date, with 15 additional applications currently pending.”

 

About Q Therapeutics, Inc.

 
Headquartered in Salt Lake City, Utah, Q Holdings, Inc., dba Q Therapeutics, Inc., is a fully reporting, non-trading company, engaged in developing adult stem cell therapies to treat debilitating diseases of the central nervous system. The Company’s first product, Q-Cells®, is a cell-based therapeutic intended to restore or preserve normal activity of neurons by providing essential support functions that occur in healthy central nervous system tissues. Q-Cells may be applicable to a wide range of central nervous system diseases, including demyelinating conditions such as multiple sclerosis, transverse myelitis, cerebral palsy, and stroke, as well as other neurodegenerative diseases and injuries, such as ALS (Lou Gehrig’s disease), spinal cord injury, Parkinson’s disease and Alzheimer’s disease. Q Therapeutics’ initial clinical target is ALS, with a first IND submission expected in 2013. For more information, visit www.qthera.com.

 

 
 

 

Cautionary Statement Regarding Forward Looking Information

 

This news release may contain forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Q Therapeutics’ technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of its intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in Q Therapeutics’ periodic reports, including the quarterly report on Form 10-Q for the period ended September 30, 2012.

 

FOR MORE INFORMATION:

HANOVER|ELITE

Dodi Handy or Kathy Addison

407-585-1080 or via email at QCEL@hanoverelite.com

 

 
 

 

 GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X1$.17AI9@``34T`*@````@`#`$```,````!`=T```$!``,````!`-<` M``$"``,````#````G@$&``,````!``(```$2``,````!``$```$5``,````! M``,```$:``4````!````I`$;``4````!````K`$H``,````!``(```$Q``(` M```>````M`$R``(````4````TH=I``0````!````Z````2``"``(``@`+<;` M```G$``MQL```"<0061O8F4@4&AO=&]S:&]P($-3-2XQ(%=I;F1O=W,`,C`Q M,CHQ,3HR.2`P,SHQ.3HU,``````$D```!P````0P,C(QH`$``P````$``0`` MH`(`!`````$```#^H`,`!`````$```!S``````````8!`P`#`````0`&```! M&@`%`````0```6X!&P`%`````0```78!*``#`````0`"```"`0`$`````0`` M`7X"`@`$`````0``#X@`````````2`````$```!(`````?_8_^T`#$%D;V)E M7T--``'_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP, M#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!(`*`#`2(``A$!`Q$!_]T`!``* M_\0!/P```04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`` M```````!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05! M46$3(G&!,@84D:&Q0B,D%5+!8C,T)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V M-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3 M!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1`Q$`/P#U1(E)K6/M/3*'%M;(^TN&FXGW-ID M?F-;]-&,3(T%LI<(LNAG?6O`QW&O'!RK!H2P@5C_`*Z?I?\`6U5QNN_6#J+C M]AQ*@P[<6#_KVZMKG?U&/6%TW"=G9E6(T[0\S8X=F-U?'_4L7?4TUT5,J MI:&5UC:QHX`"DF(PT`L^*V)E/6Z'@XMV1];J6%YIQK0.6U;G$?V'/K<[^RJM M'UOR0Z,C&:Z)#_3):X$?\';_`-^>NGAF,#!U&ML.!#;_,$_H[/Z[7[4 M(&!-2C]BIB0%QEMW=?I_5L+J#3]G?[V_2K=H\#^JKH7G5;[*K&VU.-=M>K'C MD'_OR[CI/4!U'"9D1M?JRUHX#V_2C^3^>Q+)C,?)6/()>;>5"_KO1\?)?BWY M=5=U18+FEVE9MUH;D6?S=#[_`/`LN_K6?= MF?9JMLOS'9+?T&9B_FY#&_3RGL=^H>G^M^@HV1[S-SL/`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`$F+-L'H?J;4'965<1]"MC`?ZY*^G93SPVIY_Z)31N M%QV/D\"#(![D+H?J?:=^73V.RP?'5COR-7.M@`#P6_\`4]I.3E/[-8QOWEQ_ M@K.7Y"UL7SAZIMQ'GJ&([J.-C9C,3>UC'AN4[V_H7V/KE= M=5_-VO\`1^FS(]+HUP#ND]3R/JJWH5%;LCJ73NJ&S*;O;4XL^TVY]>4Q]KF; MF9&/:QU5C/\`"?RZ;%5;3UW1^KX74:[ZL=KZ;,"PX^3C7#;94YG#70ZQCV/9 M[ZKJK+*K?](CXV<,C(R:!3=4,9S6BVQFVNT.:VWU,6R?TU;-WIO=_I%S_5OJ MKCNNZ33@X`LPV9]F7U+>\.+A=797?9DNR'NNRO6?8WU6?IO4J9Z7\TJ65]4< MVUW7/LN.S$+;\/+Z"Z6;!;A4LJKVU,=MJ8[TO0_2_P""N24]HZRII:'/#2]V MQLD"7<[&_P`K1!KZAA69&1C,N:Z[###DLG^;%@-E?J'Z+=U;=_\`47%?6[ZI M]8S*G4]-Q&66.PWEV6RT5DY3\JKJ%U3<>]WI4,OL;;D?:*F_:/5]&FW+HIJ_ M2EZG]5^J/RNNY&'AU[\K(P\S'UJ:,AE/I69?3K'.%GHNMOH]3]/59BW6_P`Y M_A4E/;"RLM#@\%I&X&1!;^]_5U7*V]4^K&4W]IY&)>>EY^2RMV>\G['9;7MI MQ\C)QO6]M'JTUX]>7DX?H[ZJO5_1>A8I8WU<:6X>/;TPUUNHSF/RGWL-N(,M MVYV/75CL919ZOJ.V>C^AP_TE=5O^GQ,_%OJ^KN+]0.H;<-]QK9^U;7!F*^BN MYN1^JV.EUG47-8RO]GV^C_I/5]'TGVI3UN3US#MS[>GT8=W4K<`MLR?1;664 MOCU*6N=D6T-LR/\`",KH]9]?\A"/UNQ3F,PH-8/7LQO7QO9Z? MZQ7^D_T*2G9H^LV)?U7&Z4VC(;D9>(W/87L#6MI=[?TVY_JUW-?['U>FKS>H M4'J#NG']2K'5.I?6;HE^36,7)Z;1F7=1 MQV.+VUMRBRG`Q'WL'I69&ROU;/\`POZO^A24_P#_T?5"=%POUBP'875'D-BG M*)MJ/:?\-7_8?[O^N+NEE_6"SI;>GD=2!-;C%89_.%\:&G^5_P"!_OI^*7#+ MO>BV<;#R_0,T875*GO,57`TV'PW$;'?]N+O`O,9K)RE8GUJS6T]/^S`_I M,HAL?R![K'?VOYM5'?6VZX^CA81=<[Z&]X,_V&?2_P`Y4#TGZP=1O.1?2=[] M"^XA@:!V%?N,A[=6U`'TP?/=[K?^H_X-;P<#P9UB?,:%'+D!T&R M,>,C4KK/QNO]&RVJS)#27;,EU>1%1&31&)E8%997=C6T^I73U/I5K+&8'KW M7>_].DIZW.SL3I^+9F9E@IQZA-EA!(:)B7;0Y-B=1PLQ]M>/:'6XY#;ZB"VR MLN&]GJTV!EM?J,]]>]GO7/=6;FY/U`S:CC7_`&NW'MK9C%UF1:27O95L>YC< MJYEC=KZO6K]?T/Z3_A%7R!U3!=UFRIF7E=1R3CWT9M=-9F_J_Z'*R[;?M57^CQ4IZF_J&'CY>-AW6!F1FEXQJR#[S4WU;?V[J%N%9E4NK](OQ,AF(QXRAZM6+]LL]'%_:GZ M7_T']),]^?9@A]+NL.KS+0-EE5M+L>T8MHVOKW?M&RNW)]'=Z635TVOJ/Z7[ M7Z7J56I3W*=<(R_ZUV5UOH^TV]0?@M+6VLLH-.3]AW[GLL:WIN9CVYOM?ZS: M8L']6[7=_UQ=3U#I>%U&L,RJ]Q;]"P':]O]5X7/7_4W+#XQLFM]?\` MPP+7?^!;FN4PR8YBIZ,7!*)]*7*^N0=01B8[F7.;_.6$%K#^\UK-WJ[?^MK7 MZ!797T;$#R2XU[R7&2=Y-FO^U%NQLISLAU5I:;&-;3+C#7>[>_;_ M`)B^84DE/TY]FS_68\W;JQ:YSF26^PAH8W3_`$;@[VJ!Q>I;+VMR!-KIK>9) MK:7/+MFGT_3V;/S/^_\`S,DDI^G?LV<]XL=?Z;A5M+&?0-D/:7^[\W5CVH9Q MNI^E6QMH#]A98XN)AVYKA>WV^_V;_8OF9))3]/'&R?4MRS9_.+YF224_5%8<&-#XW`#= M$Q,:QN]RDOE5))3]5)+Y5224_522^54DE/U4DOE5))3]5)+Y5224_522^54D ME/\`_]G_[2"\4&AO=&]S:&]P(#,N,``X0DE-!`0``````!\<`5H``QLE1QP! M6@`#&R5''`%:``,;)4<<`@```DCW`#A"24T$)0``````$"ON+OB/O%#=7O=+ M[DR>%/DX0DE-!#H``````),````0`````0``````"W!R:6YT3W5T<'5T```` M!0````!#;')396YU;0````!#;')3`````%)'0D,`````26YT965N=6T````` M26YT90````!#;')M`````$UP0FQB;V]L`0````]P'1E96Y":71B M;V]L``````MP7!E M`````$YO;F4````)=&]P3W5T)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F M=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A M,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:V MQM;F]B7I[?'_]H`#`,!``(1`Q$`/P#U1(E)K6/M/3*'%M; M(^TN&FXGW-ID?F-;]-&,3(T%LI<(LNAG?6O`QW&O'!RK!H2P@5C_`*Z?I?\` M6U5QNN_6#J+C]AQ*@P[<6#_KVZMKG?U&/6%TW"=G9E6(T[0\S8X=F-U?' M_4L7?4TUT5,JI:&5UC:QHX`"DF(PT`L^*V)E/6Z'@XMV1];J6%YIQK0.6U;G M$?V'/K<[^RJM'UOR0Z,C&:Z)#_3):X$?\';_`-^>NGAF,#!U&ML.!#; M_,$_H[/Z[7[4(&!-2C]BIB0%QEMW=?I_5L+J#3]G?[V_2K=H\#^JKH7G5;[* MK&VU.-=M>K'CD'_OR[CI/4!U'"9D1M?JRUHX#V_2C^3^>Q+)C,?)6/()>;>5 M"_KO1\?)?BWY=5=U18+FEVE9MUH;D6?S=#[_`/`LN_K6?=F?9JMLOS'9+?T&9B_FY#&_3RGL=^H>G^M^@HV1[S-SL/`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`$F+-L'H?J;4'965<1]"MC`?ZY*^G9 M3SPVIY_Z)31N%QV/D\"#(![D+H?J?:=^73V.RP?'5COR-7.M@`#P6_\`4]I. M3E/[-8QOWEQ_@K.7Y"UL7SAZIMQ'GJ&([J.-C9C,3>UC'AN4[V_H M7V/KE==5_-VO\`1^FS(]+HUP#ND]3R/JJWH5%;LCJ73NJ&S*;O;4XL M^TVY]>4Q]KF;F9&/:QU5C/\`"?RZ;%5;3UW1^KX74:[ZL=KZ;,"PX^3C7#;9 M4YG#70ZQCV/9[ZKJK+*K?](CXV<,C(R:!3=4,9S6BVQFVNT.:VWU,6R?TU;- MWIO=_I%S_5OJKCNNZ33@X`LPV9]F7U+>\.+A=797?9DNR'NNRO6?8WU6?IO4 MJ9Z7\TJ65]4]WI4,OL;;D?:*F_ M:/5]&FW+HIJ_2EZG]5^J/RNNY&'AU[\K(P\S'UJ:,AE/I69?3K'.%GHNMOH] M3]/59BW6_P`Y_A4E/;"RLM#@\%I&X&1!;^]_5U7*V]4^K&4W]IY&)>>EY^2R MMV>\G['9;7MIQ\C)QO6]M'JTUX]>7DX?H[ZJO5_1>A8I8WU<:6X>/;TPUUNH MSF/RGWL-N(,MVYV/75CL919ZOJ.V>C^AP_TE=5O^GQ,_%OJ^KN+]0.H;<-]Q MK9^U;7!F*^BNYN1^JV.EUG47-8RO]GV^C_I/5]'TGVI3UN3US#MS[>GT8=W4 MK<`MLR?1;664OCU*6N=D6T-LR/\`",KH]9]?\A"/UNQ3F,PH- M8/7LQO7QO9Z?ZQ7^D_T*2G9H^LV)?U7&Z4VC(;D9>(W/87L#6MI=[?TVY_JU MW-?['U>FKS>H4'J#NG']2K'5.I?6;HE^ M36,7)Z;1F7=1QV.+VUMRBRG`Q'WL'I69&ROU;/\`POZO^A24_P#_T?5"=%PO MUBP'875'D-BG*)MJ/:?\-7_8?[O^N+NEE_6"SI;>GD=2!-;C%89_.%\:&G^5 M_P"!_OI^*7#+O>BV<;#R_0,T875*GO,57`TV'PW$;'?]N+O`O,9K)RE8G MUJS6T]/^S`_I,HAL?R![K'?VOYM5'?6VZX^CA81=<[Z&]X,_V&?2_P`Y4#TG MZP=1O.1?2=[]"^XA@:!V%?N,A[=6U`'TP?/=[K?^H_X-;P<#P9U MB?,:%'+D!T&R,>,C4KK/QNO]&RVJS)#27;,EU>1%1&31&)E8%997=C6T^I7 M3U/I5K+&8'KW7>_].DIZW.SL3I^+9F9E@IQZA-EA!(:)B7;0Y-B=1PLQ]M>/ M:'6XY#;ZB"VRLN&]GJTV!EM?J,]]>]GO7/=6;FY/U`S:CC7_`&NW'MK9C%UF M1:27O95L>YC-9F_J_Z'*R[;?M57^CQ4IZF_J&'CY>-AW6!F1FEXQJR# M[S4WU;?V[J%N%9E4NK](OQ,AF(QXRAZM M6+]LL]'%_:GZ7_T']),]^?9@A]+NL.KS+0-EE5M+L>T8MHVOKW?M&RNW)]'= MZ635TVOJ/Z7[7Z7J56I3W*=<(R_ZUV5UOH^TV]0?@M+6VLLH-.3]AW[GLL:W MIN9CVYOM?ZS:8L']6[7=_UQ=3U#I>%U&L,RJ]Q;]"P':]O]5X7/7_4 MW+#XQLFM]?\`PP+7?^!;FN4PR8YBIZ,7!*)]*7*^N0=01B8[F7.;_.6$%K#^ M\UK-WJ[?^MK7Z!797T;$#R2XU[R7&2=Y-FO^U%NQLISLAU5I:;&- M;3+C#7>[>_;_`)B^84DE/TY]FS_68\W;JQ:YSF26^PAH8W3_`$;@[VJ!Q>I; M+VMR!-KIK>9)K:7/+MFGT_3V;/S/^_\`S,DDI^G?LV<]XL=?Z;A5M+&?0-D/ M:7^[\W5CVH9QNI^E6QMH#]A98XN)AVYKA>WV^_V;_8OF9))3]/'&R?4MRS9_.+YF224_ M5%8<&-#XW`#=$Q,:QN]RDOE5))3]5)+Y5224_522^54DE/U4DOE5))3]5)+Y M5224_522^54DE/\`_]DX0DE-!"$``````%D````!`0````\`00!D`&\`8@!E M`"``4`!H`&\`=`!O`',`:`!O`'`````5`$$`9`!O`&(`90`@`%``:`!O`'0` M;P!S`&@`;P!P`"``0P!3`#4`+@`Q`````0`X0DE-#Z``````"-IM;W!T```` M`P````$`````````!P`````!``````````````````$```````````$```!D M`````````````````````0````#_____``````3_____`````/____\````` M_____P````#_____``````````#_````_P```/\```#_````_P```/\```#_ M````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\` M``#_````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P`` M`/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_```` M_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_ M````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\` M``#_````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P`` M`/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_```` M_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_ M````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\` M``#_````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P`` M`/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_```` M_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_ M````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\` M``#_````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P`` M`/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_```` M_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_ M````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\` M``#_````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P`` M`/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_```` M_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\```#_ M````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P```/\` M``#_````_P```/\```#_````_P```/\```#_````_P```/\```#_````_P`` M`/\```#_```````````````````$6````!`````!```````.5&%R9V5T4V5T M=&EN9W,````4`````$-L6QO;F<````````` M#&YO36%T=&5#;VQOF5497AT8F]O;``````096UP:&%S:7IE5F5C=&]RF]N961(:7-T;V=R86U796EG:'1/8FIC M`````0``````"5IO;F5D26YF;P````0````)8VAA;FYE;$E$;&]N9_____\` M```-96UP:&%S:7IE5&5X=&)O;VP`````$&5M<&AAG)E M4WI.5&-Z:V,Y9"(_/B`\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE M=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C`M8S`V,2`V-"XQ-#`Y M-#DL(#(P,3`O,3(O,#&UL;G,Z<&1F M/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(B!X;6QN&UL;G,Z&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UP.D-R96%T;W)4;V]L/2)!9&]B92!0 M:&]T;W-H;W`@0U,U+C$@5VEN9&]W4E0 M5$-$:6=E&UP+FEI9#HS.$4T,4,T,4$S M,SE%,C$Q.#(T,4(R1#%#031"-C0Q,R(@&UP M+FEI9#HS0D4T,4,T,4$S,SE%,C$Q.#(T,4(R1#%#031"-C0Q,R(@&UP34TZ2&ES=&]R>3X@/'AM<$U-.D1E#IX;7!M971A/B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(#P_>'!A M8VME="!E;F0](G0``9&5S8P`````````2D!\@'Z`@," M#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@ M`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`# M[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#04< M!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&609J!GL& MC`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@? M"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4) M^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY M#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX. M20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y M$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3 M@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#%B86219L M%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9 MMQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T> M'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@ M\"$<(4@A=2&A(B>K)]PH#2@_*'$HHBC4*08I M."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,+4$M=BVK M+>$N%BY,+H(NMR[N+R0O6B^1+\< M-]1B)&9T:K1O!'-4=[1\!(!4A+2)%( MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE3FY.MT\` M3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755 MPE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R& M7-9=)UUX7&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=C MZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/ M:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5&YXS'DJ>8EYYWI&>J5[!'MC M>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$ M'82`A..%1X6KA@Z&I+CDTV3MI0@E(J4])5?EAMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>I MJ:H_R#W(O,DZ MR;G*.,JWRS;+MLPUS+7--:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OL MANT1[9SN*.ZT[T#OS/!8\.7Q$S%F+P M)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5&I+16TU4H M&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_(B8J+C(V.CX*3E)66EYB9FINGM\?7Y_(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H`#`,!``(1 M`Q$`/P#U37%78JT:Y$VJWE].$!%I1JGF[0--/&[O$5Q]I$^-A\PN^3X"Q,PQ M^?\`-O04)]"WGN%'[2@+^!-G;TL)JCQ9?U5P?ESWK^8"HG MYOZ>2M;"<@]:%?U')?EBOCIA:?FAY:E'[YI;O.:$6P)$:5 M\:;G-?/42Z.9'#&F9PZ-I<*".*SA50*`<`=OIRDY9'FS&*/DT6Q^[IED,\F,\0Z/*?,?ER_P!"O/0N/CA<_N)QU85[YLL62,@X&3&0 M4OMKF:WE$EL[0N"064E3M\J8,@!3C)'-Z#Y1_,B1I([+6>K41+GM7H.0_CF# M/%7)RX97HZNK`%=P=P?$9C$.2"N!J?;`%;.25YK^:7YJ7?EW7="\GZ!;Q77F MOS'*$M3<M:W=0Z_P"6[J=+ M/5>-N+:YMW<$B:'@S(\?PM6-_B_R\5>I07,5[8QW-G*#%2('=/*E_J;Z7 M9:M:W&H1E@;>.12Q,?VPO9RG[?#EQ_:Q5A/D/\QM>U7\S?/'EC5FMAIGEHQ- M:7"(8GX2#D?58L5^%?VOAQ5+?,_YT,GY@>3=*\K:C8:IHVOW;V>HE/WDD;1L M`2CJPZU/[.*LGT/S3K[>=_,\&KZCH_\`AG3HT>P2"=3>0\=I3=I6L:@_SC_5 MQ5/8?/WDF:^L["'7;&6\U`$V,$=Q&[3<=CPH3RZ8JJ:QYT\J:->1V6JZM;65 MU*O-89I%5N'3FP_83_+?BN*K9_//DZ"RBOGUFT-G/(T4$Z2JZN\>[A2A;EP_ M;_D_:Q5-;&_LM0M(KRQG2YM)ARAN(F#HZ^*L-B,52;S_`*KJ6D>3=8U?39$C MO=.M9;J+U4]1&,2%N++5=FIXXJQ#\GOS-N_,/Y=6_F[S??65@+N>2%*4MX$X M.445M3U.?2].U:UO-1MD$D]K#,CR*C"H8@'IOBJV?SKY M3M]8CT6?5K6+596$:6;2J'+D5"?ZY&X3[>*IU7%7_]'U1BH"G,P5"S&B@$L? M88@,9%X9YV\S2Z[JK%&(L[7*M17I4?QS).P: M07H_Y5>7(Y&DUF>.J(3'9AM^)'VC_3-;FR.;BQO30I\!7,7B;^$.4&G3#Q+3 M9!VQ*4G\RZ#!K&DS6KK^\(+0.=RK#I3+,&R1RQNT4NSQDK)_K*:4 MS:XZ+J\I(6E00P!I7HQ\/`X6SZ5W0YCN2NPJ\!_.?R]J&C?G)Y-_,EXGF\OV3)::O,@+?51R95 ME<+4B*DN[?L\<51/_.2US'YL\JZ3Y,\M,FJZWK5]#+!#;,)0EO$"6GD9*K'$ M*K\;8J]A\M:2-$\MZ9I+23G=?CQ5*].AO;OR/\`E!I/E^H\SV6M7$EW;Q_#<6_IS$W#3+]N-:?;Y_:Q M55\S1ZE=^8?SV@T8M)>RPVC!(:EW@CD7ZP$"_:HE0],51>H:WY3O/,WY'3:/ M+`4LTBCO&A7^Y*B-3'*P'PL)`_P-\6*I[IM:4)6%.?SI M^UBKS?3([&W_`"Q_*6>)8X;L^99FN95`63X;@"KL/BV7CBKT'S;::?;_`)I? MF)%;ZSIEQ-K^DIIUTFK726AL);A!Q"^J#Z\2HOJ,(?L-Q7%5_FSR=^B-!\EQ M^4_-UO!YN\LZ5-/83N46PU&U+`7*(YK%SJ./%N7J1_;_`)L59CY&_.;0-.T3 MR+HVKZ3)HNH>9H"UK;6\)%I"6E:-/M&J+.XY)&.7!67]G%6GB&")_*,:4B`52[1.P#4^TW[6_P`6*H'\K[CR3?0:KY+_`#'B M=/-EAYD?5+>"02+JDT^G?-DX*X99D.S7$;O?O*FGBQ\OV%M0!EC!>G= MCN3FGGS=K#DG.09.Q5QQ5:1L<4%XEYXLEM/,UXBKQ64B52.GQ;G-II_I=7G& MZ0>.62:XIMY1U`V'F*RG!HA?TY!XJ^WZ\HS#TMV([O=UZYK!S=FWDE6NJLI5 M@"K`A@14$'J#7%7FFE_DI#Y;\SWVO>2]:FT"/5"&U'2O0BN;1V!+517XO%U; M[+8J]*"ADX24>HHU1L?';%5"/3--B;E':0QM0K58U!H>HV&*MP:=IT#B2"UA MBD`H'2-5('S`&*MQ:?817,EU%;11W4VTTZHJR./\IP.38JZ.PL8I#+';1)*U M>4BHH8UZU(%=\56PZ7IL%/0M(8N+,R\(T6C-]H[#JW?%6_T;IW-W^JP\Y`1( MWIK5@W7D:;U[XJM.E:7Q"_4X.*U*CTTH">M-L5>:>8_R6M]8\V:IKM_9:3KR MZCZ7H+JD4JR6JQ)P]*-H3QDC_;^-?4Y?MXJR7R%^6NB^5/*L7E]DCOX$FFN2 M)8PT://(9"D2/SX11UXH*_Y7VL53?6/+-EJ]]IL]Z>=OIU``4W"?W3L M?M4BZJGV>>*IK-;V]Q'Z<\22IUX2*&%1[&HQ51&EZ7P*?4X/3)Y,GII0L.AI M3KBJY=.TY)%E6UA21*!'$:AA384(%1BJXV5E]:%V8(_K8'$7'!?4X^'.G*F* MKDMK5&D=(45I6#RLJ@%F%*,Q`^)A3%7_T_5%>_G%*1I-E#^S)/4_[$5S M+TXW:,W)Y0*FC?S;G-B0X456WC]2:.,_M.H^\Y7F-!.,;OI"%>,,8'90/PS5 M$[NQ')5P,G8J[%6CT(P!!>1_FBJCS#&W, MDTUV5#_5+&W%99@IV:1R/2AY?#R^+]G%6$>5;#]*_7=02V71!'^DWE5U6(S"L0Y$<69_V53DV*H33/S*\HZE-JEM M!=/'>:+'Z^HV4\,D4\.2%S:. M*I4;'\L;_SWHLZZK9V[FUM4`:,279;BL;<@&5=^ M;;?8Q5`>7['\Q-:_+B+S3-YGGM_,]_:_I*TMX8H?J$09/4BMS`5)D0KQ5W:3 MU,58_I__`#DS:M^2]SYTN[)1KME<#3)-/4D1/>LO)&!ZB)D_>-_JLF*LN\I^ M7/S"U/RY:ZWK7FVZM]?U"%+E;6WA@%A;>HO)(O09"TH4'XV:3DV*L&_.;SI^ M9_D[R9Y0NSJQM/,%]=FQU@Q1Q-"_4^HB.K!-J%<59_H=IYG/FJ"2Q\U3ZSI% MD[VNO6-S';_!*\'J1M'+$BGDC,G-,58AY,\Y><-0_P"<@?,OD^\UB:70-'A: M>TMN$08D^E17D"\V5?4;%7J?G9]>@\O7=_H4JIJ>GHUU##(.45P(E+-!(.H$ MBCB'7XD?BV*I,/S8\O'\J6_,8*QTL6GUHV]1Z@DKZ?H5Z<_6_=5Q5__4]4'( ME6`?G!%71+6:G]W,`3X,U=\V&GY M.NS\V(YE`6T2V76XK=P*.K2(!_P0R&4LL0M]#VH*V\2GJ$4'[LU1YNUCR5<" M7CFOVD]E_P`Y.^6=1N"19ZEHMU:6CG[/KQ$NR`_S<3RQ5C7YD6%MJ7_.2GE: M6[M);G1K>S:WOYQ%*8$D<2\5>1!Q!W7]K%6SLH=Y)'D7]F,N=*MXO^<7&AM[`KJ3>7A9^FD!^LF5P`T7$+ZE3 M+]I?YL52+6O)&H:Y_P`XV>6+W3898O,_E2"*^L8^#+.LD#?OH@E`_*@Y`?S( MN*LF_,)+ZQ_)&[U'6_+R>8=:U5K>\U+3`LCQ1W,O"C%4I*8[4*J\5_EQ5C/Y M<1:BWYY:K>3PZE+%J?ER);2]O;1[=9&"QDA5XA((QQ*1QMBK'_*GESS+J/\` MSCGYM\G6EE=1>8[6_FGGL9(I(RT8EC*J6J>6[7\U/R(O-/\N^ M7W\JS"Z>>PTNXC$`:>W>I.P44FJR\J?;_P!7%4R\L_F?H^B_EE9Z+J:2VOG/ M3;`6'^&'1OK\MU%&8HUAAZRI*5Y+*G[OC^UBKSI?^<]T1[6?Z MU]8C0(5CCX?&'(^!@>.*L!_YRH6_UGRWY06+3+DW@OQ=W=A'&T\D,7I[^IZ0 M91UIUQ5FOE_7/*/ES5(-&\GVLL\GF6_2XN((K>=;>T4Q#ZQ-)(RJJ\O3^%.7 M]XV*O/O*NJ0:-_SDMYQU[4HKF#1KR!H+;4/JMP\+R*(:A61&_D;%7K&F_F!# MY@?S1+;02Q>7](LP$OKF&2`3RE)'F:/U0I,<:!5Y4^UBKQFRT#5HO^<+[^)X M7,MP5U&**GQ"V&I13\J>'I(TG^KBK__5]4X%8M^9&FR7_E6Z2/=X:34I4D)U M`R_#*I-.0;/#5.P]]Q\LVD>3A$+BU!7K3^&0G%,2]^\IZ@M]Y>L;@-R+Q@,1 M_,NQS5Y!NYV([)V.F0;'8J[`56L:80&,B\,\\WOUSS1>R*:JC"(,.S(*'-C@ MCLZ_-S2/?+XEJ.Z8>7;-[S7;&V059Y5('LIY']649Y.1ACN^@%\?N&:ZW/;Q M5)_,OE?3-?MH([L-'<6+*?A=/@;%4VB5UC57;FX M`#-0"I[F@\<574Q5U,5=3%78J[;%74Q5U,5=BK$O._Y7^5/.,]E>:G'-;ZKI MKZ-I4FFV*VLE],KRD'L2JH-O\` M5Q5,*"M>_CBKJ8J[%78JE'F;R[;>8=,.E7TLBZ=.P^NP1'AZ\0W,+L/B$;_[ MLX_;7X,53#ZE9_4OJ7HI]3]/T?J_$>GZ7'CPX].''X>.*O\`_];U37`A1G19 M%9&%5(HP/0@[88W;&0>!>:]`FT+69K1E(MW)DMG/3TR=A7VS:X\@E$.).-)2 M-C0@Y>1;03N]'_*7S`D?K:-,P4'][;U\3]I1\\UNH@;MS,4P]1#`YBN1;=1B MEHL!D2J3>:-=ATC2)KIF'JE2L"'JSG8`9=C@26J<@'A#S,[N[M5W)Y$]2S&I M;-E`4'`F;:+**[[+U/\`7"=N;&.[T?\`*WRW*))-:G0K53%:AAV/5QF%GR`[ M!S<4*>D@4S$IRK784,5\S_F+HWEW6M-T:\M+VXU#6.8TZ.TA]7U3$.4B@AA0 MHNYY8JB_*OGCR]YF^N1Z;*ZWFG2>CJ&GW$;07-NYW`EB>C#E^RWV6Q5/N0Q5 MNN*NJ,5=7%6(WWYDZ5:>:9/*XT_4+G6(K?ZZ88(`ZFWYF'.IV_`[< MN8I7*>$AMXPE&L_F3Y;LT802_7)1T2,?"3_K9;#"2TSS`/+O,/F34-@+H4,VM2ZK< M^7'_6Q5N\?\W])T77_3C>^A6:UGT>W$ MT,VJBT+@7T2L%6-W5`3:LWQ?L_%BJ#3SKJ]_Y/OM2\IWNHZY';:E`NJ:4T2P MZU8V83_2;=5D5>4X8T2YO+'6)=8M_K4BQ_6X_1N M[4`#_1;A.*'U(FK\3+\2XJP?S7?>9+#\\[V\\NV$.J:E!Y3,D=C/*T7J<;LG MC&5#?&Q'V3BJWR%J=EY?_*OS3^9-M=C5M8U?ZQJ^J)Z9@CANXD*_5?2)+)Z# M_`_+XF^UBK(=`'YDG7=#U(3^MH5Y#_N;2\N(9$GV]I!=>7-X$+71?BHDMV,G4,T?P?L\L59OY=M?S"M? M-R/=RL_EBYMF%Q%>W$,TZWB[I);>DB_NY%KZD;'BO[&*L]'3%78J[%78J__0 M]4X"JF].GW_+$!!-/,?S1\V7<=VNAV#M&Y4-M:@KU/6GT9<2&L`K@:BA`(.XH*#*^$*;1VD2:*MTJ:M%))`W M4PFC#WIWR.2&VR<8[WJGE[RCY$N;=;BQ07T1W/JN7(^:]1FOGDD.;G0@"RNT ML;*T016L*0(O[**!E!D2VB("()V/ML<0%)2G1M=M]5O=1AMVY1V$B0\O%J$M MDC%04W0`?3D0E<>F%6*^8O(-KKGF?1/,4U_@-(^GQ1>GZ7*9>$GJ`J2_ M)/AZXJF'F_RS;>:/+=]Y?O)Y8+34(_1N9(.(D],_:"E@P%?&F*I=YC_+K1?, M?E2V\O:M+/*MEZ3V>HQL(KN&:`4CFCD0#C(H]OBQ5"6OY8PPZ2;637M5N=3: M>"X;7)YE>[Y6QK&@^'TEB%?BC"?'R^/%5[?EI:F:>_75+N+7;J[AOKG5HO32 M21[:,PQ1M&%](PK&Q5H^/QXJF_EORK8Z$VH3PN\]]JMP;O4KR0*K2R\0@/%` MJJJHJJJJ,50*^0[<>>SYT&HW/Z1:T^H&W_=_5_JP;GPX\>7+G\7/EBJA;?EC MH5KK>LZA;2S167F%6_36B?"UE.[IP>7TRM8Y)%^VR-\>*H;R?^4VE^5[F)K? M5M3OK"RY?HG2[VX]6VLPPI^Z3BI;B/AC]1G]/]C%5DOY.>6KK1-;T>_N+J[M MM65G5)8+UB#ZUNZ*IC*E5XXJLD_)W2KKRW=Z/JFLZIJES=&%AK%U.&N MX3:N)(/1(58T].0<_L?&WV^6*MK^4&G&^U"_FUO59[[5=.33;^Y:=0S^DQ9) MQQ0<)4K\'#C&O\N*HV;\L-$U![Z7S!-+K<^H6`TF::Y"(19\_4X`1*@YF3]X M9?M69A*=8U/63`AAT]=2G]9;6$TJD0"KV`7U'Y/Q^'EBK,1TQ M5V*NQ5V*O__1]4XJL85/C[8HH,_OD MSD-4@0#)>(ZGKD&33(C*5(!4]5/0XJP_S/\`EQI&JUGM@+.^H:21[1D_Y2C+ MX9B.;5+&'E.M>7]5T2FWV;QG4/,'YJ:G?6\EK8PBSBD'%I6-9:'K3PR>+3B]V$LI+(/RAMG M32;VYW*SSJ`S;D\!0G\S=B)ZL_0$=]T M^TOK=[>\B6:!Q1D85&&$RQ,07F/F;\J;J!FGT,^I!NS6K_;'^H>_^KF;CS][ MC9,?8W]L"M% MA2O;&E=W(`ID=U0M[I>G7JA;VWCN%'^_%!RP2(8&`*"C\H^6$;FNEV]3_P`5 MC)>(5X`F-O:Q6\8CAC6&->B1@!1]V5RD2R$0%9:*/"O?"EL$5IX],B.:KLDK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK__4]`ZV)K36)+^6 MUDNK,VQCJHY!6KUIV_UL51GE:WE'E^!+AS()`6&YV4M4+7KMBJCI^DRPV>ID MH_KR/.MO\;&L;?8&YQ5;8Z;K,5UI;SR\HX8)%G&^SL@"U^G%5+1-.U."WO8K MB-Q.Z2A92[$L6^R`2:+BK6B6.LZ/\N*K8M!U&'1;H+,S7-Q"JI$"RK&5&].1 M8U/SQ5L6FI+HL(B@=;FWN$E>$,0SH@^*C,3RKBJ)M+*ZNCJPR M!!9M&Y41\>H8`]SORQ5JXL[W_$4=Q#`[(W$3^H6],`#9DXD#EV.V*LH&XQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7U0_V3T^GIBJU/ ML]OHZ8JNQ5V*MG%6AW^>*N&*N.*N/48JWBKL5:Q5O%78J[%78J[%78J[%78J 9[%78J[%78J[%78J[%78J[%78J[%78J__V3\_ ` end